Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Oligodendroglioma 1Mesothelioma, Malignant 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ependymoma 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 16Blood Specimen Collection 8Temozolomide 5Magnetic Resonance Imaging 5Bevacizumab 4Yoga 3Radiotherapy, Intensity-Modulated 3Biopsy 3Transcranial Magnetic Stimulation 2Surveys and Questionnaires 2Restraint, Physical 2Radiosurgery 2Radiation 2Psychosocial Intervention 2Proton Therapy 2Physical Therapy Modalities 2Palliative Care 2Mind-Body Therapies 2Mental Status and Dementia Tests 2Heart Rate 2Gadolinium DTPA 2Exercise 2Elasticity Imaging Techniques 2Drug Therapy 2Diffusion Tensor Imaging 2Congresses as Topic 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vandetanib 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Glioma × Etanidazole × Clear all
NCT00430079 2013-01-16

Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma

National Cancer Institute (NCI)

Phase NA Terminated
48 enrolled
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡